Jiawei Erzhiwan improves menopausal metabolic syndrome by enhancing insulin secretion in pancreatic β cells

详细信息    查看全文

• 作者：Xiao-Meng WAN^a ; ^Δ ; Mu ZHANG^a ; ^Δ ; Pei ZHANG^a ; Zhi-Shen XIE^a ; Feng-Guo XU^a ; Ping ZHOU^a ; Shi-Ping MA^a ; ^{spma2009hz@yahoo.cn} ; Xiao-Jun XU^a ; ^b ; ^{xiaojunxu2000@163.com}
• 关键词：Jiawei Erzhiwan ; Menopausal metabolic syndrome ; Estrogen receptor ; Glucose tolerance ; Islet β cell
• 刊名：Chinese Journal of Natural Medicines
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：14
• 期：11
• 页码：823-834
• 全文大小：4690 K
• 卷排序：14

文摘

Menopausal metabolic syndrome (MMS) is a series of syndrome caused by ovarian function decline and hormone insufficiency, and is a high risk factor for cardiovascular diseases (CVD) and type II diabetes mellitus (T2DM). Erzhiwan (EZW), composed of Herba Ecliptae and Fructus Ligustri Lucidi, is a traditional Chinese herbal formula that has been used to treat menopausal syndrome for many years. We added Herba Epimedii, Radix Rehmanniae, and Fructus Corni into EZW, to prepare a new formula, termed Jiawei Erzhiwan (JE). The present study was designed to determine the anti-MMS effects of JE using ovariectomized (OVX) adult female rats that were treated with JE for 4 weeks, and β-tc-6 cells and INS cells were used to detected the protect effectiveness of JE. Our results showed JE could increase insulin sensitivity and ameliorated hyperlipidemia. Metabolomics analysis showed that the serum levels of branched and aromatic amino acids were down-regulated in serum by JE administration. Moreover, JE enhanced the function of islet β cells INS-1 and β-tc-6, through increasing the glucose stimulated insulin secretion (GSIS), which was abolished by estrogen receptor (ER) antagonist, indicating that JE functions were mediated by ER signaling. Additionally, JE did not induce tumorigenesis in rat mammary tissue or promoted proliferation of MCF-7 and Hela cells. In conclusion, our work demonstrated that JE ameliorated OVX-induced glucose and lipid metabolism disorder through activating estrogen receptor pathway and promoting GSIS in islet β cells, thus indicating that JE could be a safe and effective medication for MMS therapy.